Table of contents
Volume 86, Issue 5
Published online 4 March 2002 (665-842)
Clinical |
Epidemiology |
Molecular and Cellular Pathology |
Experimental Therapeutics
Conference Report
Beatson International Cancer Conference: Genomic Regulation and Cancer FREE
K E Gordon, A P MacLaren and N I Barr
Br J Cancer 86: 665-668; doi:10.1038/sj.bjc.6600146
Clinical
Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer FREE
M B Polee, F A L M Eskens, M E L van der Burg, T A W Splinter, P D Siersema, H W Tilanus, J Verweij, G Stoter and A van der Gaast
Br J Cancer 86: 669-673; doi:10.1038/sj.bjc.6600166
Influence of pathological tumour variables on long-term survival in resectable gastric cancer FREE
A Cuschieri, I C Talbot and S Weeden on behalf of the MRC Upper GI Cancer Working Party
Br J Cancer 86: 674-679; doi:10.1038/sj.bjc.6600161
A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer FREE
T R J Evans, K W Colston, F J Lofts, D Cunningham, D A Anthoney, H Gogas, J S de Bono, K J Hamberg, T Skov and J L Mansi
Br J Cancer 86: 680-685; doi:10.1038/sj.bjc.6600162
Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer FREE
C C Parker, A R Norman, R A Huddart, A Horwich and D P Dearnaley
Br J Cancer 86: 686-691; doi:10.1038/sj.bjc.6600160
Sequential or alternating administration of docetaxel (Taxotere®) combined with FEC in metastatic breast cancer: a randomised phase II trial FREE
M Spielmann, M Tubiana-Hulin, M Namer, H Mansouri, P h Bougnoux, N Tubiana-Mathieu, V Lotz and J C Eymard
Br J Cancer 86: 692-697; doi:10.1038/sj.bjc.6600165
Epidemiology
Randomised 
-carotene supplementation and incidence of cancer and cardiovascular disease in women: is the association modified by baseline plasma level? FREE
I-M Lee, N R Cook, J E Manson and J E Buring
Br J Cancer 86: 698-701; doi:10.1038/sj.bjc.6600147
Low prevalence of Epstein–Barr virus in incident gastric adenocarcinomas from the United Kingdom FREE
D E Burgess, C B Woodman, K J Flavell, D C Rowlands, J Crocker, K Scott, J P Biddulph, L S Young and P G Murray
Br J Cancer 86: 702-704; doi:10.1038/sj.bjc.6600107
Prevalence and determinants of human papillomavirus genital infection in men FREE
S Franceschi, X Castellsagué, L Dal Maso, J S Smith, M Plummer, C Ngelangel, S Chichareon, J Eluf-Neto, K V Shah, P J F Snijders, C J L M Meijer, F X Bosch and N Muñoz
Br J Cancer 86: 705-711; doi:10.1038/sj.bjc.6600194
Diet and ovarian cancer risk: a case–control study in China FREE
M Zhang, Z Y Yang, C W Binns and A H Lee
Br J Cancer 86: 712-717; doi:10.1038/sj.bjc.6600085
A follow-up study of breast and other cancers in families of an unselected series of breast cancer patients FREE
K E Bennett, A Howell, D G R Evans and J M Birch
Br J Cancer 86: 718-722; doi:10.1038/sj.bjc.6600106
Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women FREE
F Clavel-Chapelon and the E3N-EPIC Group
Br J Cancer 86: 723-727; doi:10.1038/sj.bjc.6600124
Alpha-foetoprotein in umbilical cord in relation to severe pre-eclampsia, birth weight and future breast cancer risk FREE
L J Vatten, P R Romundstad, R A Ødegård, S T Nilsen, D Trichopoulos and R Austgulen
Br J Cancer 86: 728-731; doi:10.1038/sj.bjc.6600125
A case–control study of childhood leukaemia and paternal occupational contact level in rural Sweden FREE
L Kinlen, J Jiang and K Hemminki
Br J Cancer 86: 732-737; doi:10.1038/sj.bjc.6600113
Molecular and Cellular Pathology
Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression FREE
A Krieg, C Mahotka, T Krieg, H Grabsch, W Müller, S Takeno, C V Suschek, M Heydthausen, H E Gabbert and C D Gerharz
Br J Cancer 86: 737-743; doi:10.1038/sj.bjc.6600153
An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation FREE
S Cascinu, F Graziano, V Catalano, M P Staccioli, M C Rossi, A M Baldelli, S Barni, A Brenna, S Secondino, P Muretto and G Catalano
Br J Cancer 86: 744-749; doi:10.1038/sj.bjc.6600155
p53 as a potential predictive factor of response to chemotherapy: feasibility of p53 assessment using a functional test in yeast from trucut biopsies in breast cancer patients FREE
H Bonnefoi, A Ducraux, S Movarekhi, M F Pelte, S Bongard, E Lurati and R Iggo
Br J Cancer 86: 750-755; doi:10.1038/sj.bjc.6600105
Analysis of CHK2 in vulval neoplasia FREE
A Reddy, M Yuille, A Sullivan, C Repellin, A Bell, J A Tidy, D J Evans, P J Farrell, B Gusterson, M Gasco and T Crook
Br J Cancer 86: 756-760; doi:10.1038/sj.bjc.6600131
Tamoxifen induction of angiogenic factor expression in endometrium FREE
S Hague, S Manek, M K Oehler, I Z MacKenzie, R Bicknell and M C P Rees
Br J Cancer 86: 761-767; doi:10.1038/sj.bjc.6600157
Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma FREE
H Sasamura, A Takahashi, N Miyao, M Yanase, N Masumori, H Kitamura, N Itoh and T Tsukamoto
Br J Cancer 86: 768-773; doi:10.1038/sj.bjc.6600152
Experimental Therapeutics
The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1 FREE
G A Potter, L H Patterson, E Wanogho, P J Perry, P C Butler, T Ijaz, K C Ruparelia, J H Lamb, P B Farmer, L A Stanley and M D Burke
Br J Cancer 86: 774-778; doi:10.1038/sj.bjc.6600197
Thiram inhibits angiogenesis and slows the development of experimental tumours in mice FREE
M Marikovsky
Br J Cancer 86: 779-787; doi:10.1038/sj.bjc.6600078
Inhibition of the alpha-
integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo
FREE
M A Buerkle, S A Pahernik, A Sutter, A Jonczyk, K Messmer and M Dellian
Br J Cancer 86: 788-795; doi:10.1038/sj.bjc.6600141
Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo FREE
E Van Valckenborgh, H De Raeve, L Devy, S Blacher, C Munaut, A Noël, E Van Marck, I Van Riet, B Van Camp and K Vanderkerken
Br J Cancer 86: 796-802; doi:10.1038/sj.bjc.6600137
Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model FREE
M C M Mah-Becherel, J Céraline, G Deplanque, M-P Chenard, J-P Bergerat, J-P Cazenave and C Klein-Soyer
Br J Cancer 86: 803-810; doi:10.1038/sj.bjc.6600142
A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug FREE
M de Graaf, E Boven, D Oosterhoff, I H van der Meulen-Muileman, G A Huls, W R Gerritsen, H J Haisma and H M Pinedo
Br J Cancer 86: 811-818; doi:10.1038/sj.bjc.6600143
Sequence-dependent effects of ZD1839 ('Iressa') in combination with cytotoxic treatment in human head and neck cancer FREE
N Magné, J L Fischel, A Dubreuil, P Formento, S Marcié, J-L Lagrange and G Milano
Br J Cancer 86: 819-827; doi:10.1038/sj.bjc.6600103
Superantigen reactive V6+ T cells induce perforin/granzyme B mediated caspase-independent apoptosis in tumour cells FREE
S Müerköster, M A Weigand, C Choi, H Walczak, V Schirrmacher and V Umansky
Br J Cancer 86: 828-836; doi:10.1038/sj.bjc.6600104
ALA and ALA hexyl ester in free and liposomal formulations for the photosensitisation of tumour organ cultures FREE
A Casas, C Perotti, M Saccoliti, P Sacca, H Fukuda and A M del C Batlle
Br J Cancer 86: 837-842; doi:10.1038/sj.bjc.6600144
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
